Name: Cigna Group (NYSE:CI) | Balance Sheet: Assets
Creator: Stock Analysis on Net

Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Cigna Group, consolidated balance sheet: assets

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash and cash equivalents	7,550)	7,822)	5,924)	5,081)	10,182)
Investments	665)	925)	905)	920)	1,331)
Noninsurance customer receivables	11,879)	8,044)	6,899)	6,274)	5,534)
Pharmaceutical manufacturers receivable	10,914)	8,169)	7,108)	5,463)	4,676)
Insurance customer receivables	3,199)	2,359)	2,963)	2,932)	1,789)
Other receivables	162)	272)	248)	456)	192)
Less: Accounts receivable, net classified as Assets of businesses held for sale	(1,927)	(1,122)	—)	(54)	—)
Accounts receivable, net	24,227)	17,722)	17,218)	15,071)	12,191)
Inventories	6,692)	5,645)	4,777)	3,722)	3,165)
Other current assets	2,732)	2,169)	1,296)	1,283)	930)
Assets of businesses held for sale	7,004)	3,068)	—)	10,057)	—)
Current assets	48,870)	37,351)	30,120)	36,134)	27,799)
Long-term investments	15,128)	17,985)	16,288)	18,438)	23,262)
Reinsurance recoverables	4,378)	4,835)	4,743)	4,970)	5,200)
Property and equipment	3,654)	3,695)	3,774)	3,692)	4,205)
Goodwill	44,370)	44,259)	45,811)	45,811)	44,648)
Other intangible assets	29,417)	30,863)	32,492)	34,102)	35,179)
Other assets	2,786)	3,421)	3,426)	3,405)	6,072)
Separate account assets	7,278)	7,430)	7,278)	8,337)	9,086)
Assets of businesses held for sale, non-current	—)	2,922)	—)	—)	—)
Non-current assets	107,011)	115,410)	113,812)	118,755)	127,652)
Total assets	155,881)	152,761)	143,932)	154,889)	155,451)

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Total assets remained relatively stable over the five-year period, ending at 155,881 million USD in 2024, which is nearly identical to the 155,451 million USD reported in 2020. However, a significant internal reallocation of capital is evident, characterized by a marked increase in current assets and a corresponding decline in non-current assets.

Current Asset Expansion: Current assets grew substantially from 27,799 million USD in 2020 to 48,870 million USD in 2024. This growth was primarily driven by a surge in accounts receivable, which doubled from 12,191 million USD to 24,227 million USD over the period. Specifically, noninsurance customer receivables and pharmaceutical manufacturers receivables both showed strong upward trajectories, each increasing from approximately 4.6 billion to 11.8 billion and 10.9 billion USD, respectively. Inventories also followed a consistent growth pattern, increasing from 3,165 million USD in 2020 to 6,692 million USD in 2024.
Liquidity Trends: Cash and cash equivalents exhibited volatility, dropping from 10,182 million USD in 2020 to a low of 5,081 million USD in 2021, before recovering to 7,550 million USD by the end of 2024. Short-term investments saw a gradual decline, decreasing from 1,331 million USD in 2020 to 665 million USD in 2024.
Non-Current Asset Contraction: Non-current assets decreased from 127,652 million USD in 2020 to 107,011 million USD in 2024. This contraction is largely attributable to a reduction in long-term investments, which fell from 23,262 million USD to 15,128 million USD. Additionally, other intangible assets experienced a steady decline from 35,179 million USD in 2020 to 29,417 million USD in 2024, while goodwill remained relatively stagnant, fluctuating slightly around the 44 billion USD mark.
Strategic Divestitures and Asset Reclassification: The presence of assets held for sale indicates periodic strategic shifts. These assets appeared significantly in 2021 (10,057 million USD) and again in 2024 (7,004 million USD current assets). The corresponding negative adjustments to accounts receivable for businesses held for sale increased from -54 million USD in 2021 to -1,927 million USD in 2024, suggesting a scaling up of divestiture activities toward the end of the analyzed period.

Overall, the financial position has shifted toward a more liquid asset structure. The growth in operational receivables and inventories suggests an expansion in business volume or changes in credit terms, while the reduction in long-term investments and intangible assets indicates a move away from long-term capital holdings and a possible amortization or impairment of intangible value.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?